the staff of the Ridgewood blog
Ridgewood NJ, A promising drug called remdesivir may shorten hospital stays for patients with COVID-19 and perhaps speed their recoveries while diminishing the odds of death, according to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who on Wednesday described federal next steps based on the new, positive study.
White House health advisor Dr. Anthony Fauci said Wednesday that data from a coronavirus drug trial testing Gilead Sciences’ antiviral drug remdesivir showed “quite good news” and sets a new standard of care for Covid-19 patients. Speaking to reporters from the White House, Fauci said he was told data from the trial showed a “clear-cut positive effect in diminishing time to recover.”
Fauci, who for weeks has discounted anecdotes about improved results for patients who were so sick they received remdesivir as a last-ditch therapy, said the antiviral drug is now a “new standard of care” for those hospitalized with COVID-19 (CNBC).
Remdesivir, made by Gilead Sciences, is a therapy, not a vaccine, and needs more review, but Fauci called early results “very optimistic” during an event in the Oval Office with President Trump and visiting Louisiana Gov. John Bel Edwards (D).
The Food and Drug Administration is in talks with Gilead to make the drug widely available to the patient population that could benefit. The news cheered investors and sent the stock market soaring.
Nope, not buying this yet….
I want of marijuana would help.